Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Corona LifeCare A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1%   Bankruptcy risk   3.1% 1.4% 3.2% 1.0% 1.3% 1.2% 12.2% 9.8%   Credit score (0-100)   58 80 57 86 79 82 18 25   Credit rating   BBB A BBB A A A BB BB   Credit limit (kDKK)   0.0 18.7 0.0 212.4 64.2 112.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,507 3,617 1,952 2,796 3,544 2,657 0.0 0.0   EBITDA   387 532 -126 886 1,607 960 0.0 0.0   EBIT   330 473 -165 861 1,574 949 0.0 0.0   Pre-tax profit (PTP)   21.9 384.6 -148.8 813.1 1,537.9 901.9 0.0 0.0   Net earnings   16.0 296.9 -120.2 634.1 1,199.3 703.2 0.0 0.0   Pre-tax profit without non-rec. items   21.9 385 -149 813 1,538 902 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   167 108 69.3 44.4 11.1 0.0 0.0 0.0   Shareholders equity total   1,173 1,470 1,350 1,984 2,433 2,586 1,536 1,536   Interest-bearing liabilities   1,268 1,050 417 422 23.4 328 0.0 0.0   Balance sheet total (assets)   3,853 3,837 3,546 3,956 3,783 3,779 1,536 1,536   Net Debt   945 1,035 26.1 -1,814 -1,442 -1,328 -1,536 -1,536     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,507 3,617 1,952 2,796 3,544 2,657 0.0 0.0   Gross profit growth   8.9% 3.1% -46.0% 43.3% 26.8% -25.0% -100.0% 0.0%   Employees   6 6 6 6 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,853 3,837 3,546 3,956 3,783 3,779 1,536 1,536   Balance sheet change%   -3.4% -0.4% -7.6% 11.6% -4.4% -0.1% -59.4% 0.0%   Added value   330.1 472.7 -165.2 861.2 1,573.8 949.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   52 -118 -78 -50 -67 -22 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.4% 13.1% -8.5% 30.8% 44.4% 35.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.5% 12.4% -2.2% 23.1% 40.7% 25.1% 0.0% 0.0%   ROI %   14.2% 19.2% -3.8% 41.5% 64.8% 35.4% 0.0% 0.0%   ROE %   1.4% 22.5% -8.5% 38.0% 54.3% 28.0% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   30.4% 38.3% 38.1% 50.1% 64.3% 68.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   244.2% 194.7% -20.7% -204.7% -89.7% -138.3% 0.0% 0.0%   Gearing %   108.1% 71.5% 30.9% 21.3% 1.0% 12.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   26.3% 7.8% 9.2% 12.6% 16.6% 27.1% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   0.5 0.5 0.5 1.5 1.7 2.1 0.0 0.0   Current Ratio   1.4 1.6 1.6 2.0 2.8 3.2 0.0 0.0   Cash and cash equivalent   323.0 15.3 390.7 2,235.9 1,464.9 1,655.8 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   961.2 1,317.2 1,216.0 1,875.1 2,411.6 2,576.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   55 79 -28 144 525 316 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   65 89 -21 148 536 320 0 0   EBIT / employee   55 79 -28 144 525 316 0 0   Net earnings / employee   3 49 -20 106 400 234 0 0